| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/08/1999 | EP0939630A1 Use of benzopyranols to treat neurological disorders |
| 09/08/1999 | EP0939626A1 Galenic formula with extended release of milnacipran |
| 09/08/1999 | EP0939623A1 Oral delayed immediate release formulation and method of preparation therefor |
| 09/08/1999 | EP0730594B1 9-HYDROXY-PYRIDO [1,2-a]PYRIMIDIN-4-ONE ETHER DERIVATIVES |
| 09/08/1999 | EP0670713B1 A pharmaceutical formulation |
| 09/08/1999 | CN1228091A Substituted 6,6-hetero-bicyclic derivatives |
| 09/08/1999 | CN1228024A Use of K-252A derivative for treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 09/08/1999 | CN1227871A Nuclein structural body for gene treating method |
| 09/08/1999 | CN1227841A Piperazine derivatives as 5-HT1A antagonists |
| 09/07/1999 | US5948933 Tropane analogs and methods for inhibition of monoamine transport |
| 09/07/1999 | US5948913 Hydrate for drug use |
| 09/07/1999 | US5948811 Psychological disorders; parkinson's disease |
| 09/07/1999 | US5948806 Treatment of Parkinson's disease with (+)2-(ethyl-2,3-dihydrobenzofuranyl)-2-Imidazoline (dexefaroxan or (+) efaroxan) |
| 09/07/1999 | US5948804 Anaesthetic premedication |
| 09/07/1999 | US5948802 Stroke, anticonvulsants, antiepilepic agents, antiasthma agents, migraines, nervous system disorders, sexual disorders, incotinence |
| 09/07/1999 | US5948788 Normorphine and normorphinone derivatives |
| 09/07/1999 | US5948782 Antiinflammatory agent; rheumatic diseases |
| 09/07/1999 | US5948767 Transport of active material into cells; drug delivery |
| 09/07/1999 | US5948763 Inhibitory peptide having a length of three to fifteen amino acids and comprising a portion of three to eight amino acids, which portion is hydrophobic and has one or more .beta.-sheet blocking amino acid residues therein |
| 09/07/1999 | US5948760 Therapeutic use of superoxide dismutases |
| 09/07/1999 | US5948626 Method of detecting human phospholipase inhibitor |
| 09/07/1999 | US5948434 Administering dehydroepiandrosterone or dehydroepiandrosterone sulphate via transdermal patch |
| 09/07/1999 | US5948402 Method of using IL-11 for treating antibiotic induced diarrhea |
| 09/07/1999 | CA2098944C Novel pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present |
| 09/07/1999 | CA1340726C Redox amino acids and peptides containing them |
| 09/02/1999 | WO1999043840A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/02/1999 | WO1999043813A1 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 09/02/1999 | WO1999043807A2 Human channel-related molecules |
| 09/02/1999 | WO1999043806A1 Human smn-like protein |
| 09/02/1999 | WO1999043805A1 Human protein kinase c inhibitor |
| 09/02/1999 | WO1999043693A1 36 human secreted proteins |
| 09/02/1999 | WO1999043681A1 4-(4-piperidylmethylamino) substituted heteroaryl fused pyridines: gaba brain receptor ligands |
| 09/02/1999 | WO1999043680A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 09/02/1999 | WO1999043677A1 SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PYRIDAZINE |
| 09/02/1999 | WO1999043676A2 6,9-disubstituted 2-[trans-(4- aminocyclohexyl) amino]purines |
| 09/02/1999 | WO1999043675A1 6,9-disubstituted 2-[trans-(4- aminocyclohexyl) amino]purines |
| 09/02/1999 | WO1999043670A1 Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d4 receptor antagonists |
| 09/02/1999 | WO1999043661A2 Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands |
| 09/02/1999 | WO1999043657A1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists |
| 09/02/1999 | WO1999043358A1 Dendrimeric fullerene derivatives, method for producing same and their use as neuroprotectors |
| 09/02/1999 | WO1999043354A2 Method for treating painful conditions of the anal region and compositions therefor |
| 09/02/1999 | WO1999043334A1 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 09/02/1999 | WO1999043319A1 Agents with serotonin-related activity for the treatment for sleep apnea |
| 09/02/1999 | WO1999043286A2 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 09/02/1999 | WO1999043285A2 Sulphonamide derivatives |
| 09/02/1999 | WO1999030720A8 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 09/02/1999 | WO1999025716A9 Pyranones, method for the production and use thereof |
| 09/02/1999 | WO1999021540A3 Method of reducing craving in mammals |
| 09/02/1999 | WO1998030693A9 Tumor necrosis factor receptor 5 |
| 09/02/1999 | WO1998027113A8 Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5 |
| 09/02/1999 | CA2322167A1 Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands |
| 09/02/1999 | CA2322139A1 Sulphonamide derivatives |
| 09/02/1999 | CA2321970A1 36 human secreted proteins |
| 09/02/1999 | CA2321883A1 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 09/02/1999 | CA2321830A1 Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d4 receptor antagonists |
| 09/02/1999 | CA2321747A1 Human smn-like protein |
| 09/02/1999 | CA2321746A1 Human protein kinase c inhibitor |
| 09/02/1999 | CA2321667A1 Human channel-related molecules |
| 09/02/1999 | CA2321559A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 09/02/1999 | CA2321178A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/02/1999 | CA2317416A1 Substituted 1,2,4-triazolo¬3,4-a|pyridazine |
| 09/01/1999 | EP0939131A2 Aminopeptidases |
| 09/01/1999 | EP0939127A2 Humanized immunoglobulins and their production and use |
| 09/01/1999 | EP0939124A2 MGBP1 sequences |
| 09/01/1999 | EP0939123A2 Estrogen receptor-related polypetide SBPERR4 |
| 09/01/1999 | EP0939077A2 3-Substituted 1-arylindole compounds as 5-HT2 antagonists |
| 09/01/1999 | EP0938558A2 Gaba a receptor subunit epsilon-related protein |
| 09/01/1999 | EP0938496A1 Heptapeptide oxytocin analogues |
| 09/01/1999 | EP0938485A1 Benzoxazole derivative with an affinity to binding sites of amino acid receptors |
| 09/01/1999 | EP0938483A2 Muscarinic antagonists |
| 09/01/1999 | EP0938477A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors |
| 09/01/1999 | EP0938471A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 09/01/1999 | EP0938336A1 A method for enhancing long-term memory in a subject and uses thereof |
| 09/01/1999 | EP0938333A1 Method of enhancing the delivery of growth factors |
| 09/01/1999 | EP0938328A1 Method of inhibiting fibrosis with a somatostatin agonist |
| 09/01/1999 | EP0938309A1 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 09/01/1999 | EP0938304A1 Treatment of spasticity, convulsions by isovaleric acid derivatives cns depressants |
| 09/01/1999 | EP0835254B1 Oxazolidinone derivatives, their preparation and therapeutical use |
| 09/01/1999 | EP0691842B1 Lidocaine aerosol anaesthetic |
| 09/01/1999 | EP0687267B1 Pyrrolo-pyridine derivatives as ligands of dopamine receptor |
| 09/01/1999 | EP0672055B1 Neuropeptide y antagonists |
| 09/01/1999 | EP0650475B1 4-amino-n-(4-methyl-4-piperidinyl)-2-methoxybenzamides, their preparation and their use as 5-ht2 antagonists |
| 09/01/1999 | EP0643780B2 Multiple solvent cleaning system |
| 09/01/1999 | CN1227554A Substituted 6,5-hetero-bicyclic derivatives |
| 09/01/1999 | CN1227552A Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives |
| 09/01/1999 | CN1227550A Troponyl piperazines as selective dopamine D4 receptor ligands |
| 09/01/1999 | CN1227544A Tetrahydroquinoline derivatives as EAA antagonists |
| 09/01/1999 | CN1227487A Pharmaceutical compositions containing mesembrine and related compounds |
| 09/01/1999 | CN1227486A Pharmaceutical compositions comprising S-(-)-N-propargyl-1-amino indan |
| 09/01/1999 | CN1227114A Sobering and body building tea made of natural plant |
| 09/01/1999 | CN1227102A Medicine for giving up medicinal dependence |
| 09/01/1999 | CN1227099A Novel treatment agent |
| 09/01/1999 | CN1044910C Indole derivatives |
| 09/01/1999 | CN1044909C 吲哚衍生物 Indole derivatives |
| 09/01/1999 | CN1044905C Anellated dihydropyridines and its producing method and medicinal composition comprising them |
| 08/31/1999 | US5945577 Nuclear transfer units for cells |
| 08/31/1999 | US5945566 Central nervous system |
| 08/31/1999 | US5945539 Enzyme inhibitor |
| 08/31/1999 | US5945505 Human phospholemman-like protein |
| 08/31/1999 | US5945454 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives |